Dianthus Therapeutics, Inc. (DNTH)
NASDAQ·Healthcare·Biotechnology
$83.02
+8.58%
Mkt Cap $3.19B
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (17 analysts)
$109.56
Range $55.00 – $145.00
Implied Upside
+32.0%
Consensus $109.56 vs current $83.02
NASDAQ·Healthcare·Biotechnology
$83.02
+8.58%
Mkt Cap $3.19B
Buy
13
Hold
0
Sell
0
Price Target (17 analysts)
$109.56
Range $55.00 – $145.00
+32.0%
Consensus $109.56 vs current $83.02